Prospective Cohort Study for Lymphoma: Samsung Lymphoma Cohort Study IV
NCT07032103
·
clinicaltrials.gov ↗
RECRUITING
Status
2000
Enrollment
OTHER
Sponsor class
Conditions
Lymphoma
Interventions
DRUG:
Immunochemotherapy
Sponsor
Samsung Medical Center